CAT No: OPO-011
CAS No: 96497-82-4
Synonyms/Alias: 96497-82-4;sGnRH-A;SGNRHA;WHI058YG4Q;L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-arginyl-L-tryptophyl-L-leucyl-N-ethyl-;UNII-WHI058YG4Q;DTXSID70873506;[D-Arg6,Pro9-NEt]Salmon GnRH;HY-P3582;DA-48725;FD110399;6-Arg-7-trp-8-leu-9-N-Et-pronh2-LHRH;CS-0615998;(Arg(6)-trp(7)-leu(8)-pro(9)-net)GNRH;5-Oxo-pro-his-trp-ser-tyr-gly-trp-leu-pro-glynh2;GNRH, arg(6)-trp(7)-leu(8)-N-Et-proNH2(9)-;LHRH, arg(6)-trp(7)-leu(8)-N-Et-pronh2(9)-;PGLU-HIS-TRP-SER-TYR-D-ARG-TRP-LEU-PRO-NHET;PGLU-HIS-TRP-SER-TYR-GLY-TRP-LEU-PRO-GLY-NHET;Q27292635;(Des-Gly10,D-Arg6,Pro-NHEt9)-LHRH (salmon) acetate salt;6-Arginyl-7-tryptophyl-8-leucyl-9-N-ethylprolinamide-LHRH;(Des-Gly10,D-Arg6,Pro-NHEt 9)-LHRH (salmon) acetate salt;DES-GLY10, D-ARG6, TRP7, LEU8) - LHRH, ETHYL AMIDE;LHRH, arginyl(6)-tryptophyl(7)-leucyl(8)-N-ethylprolinamide(9)-;
Chemical Name: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-5-(diaminomethylideneamino)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C64H83N17O12 |
M.W/Mr. | 1282.4 |
Sequence | One Letter Code:XHWSYRWLP Three Letter Code:H-Pyr-His-Trp-Ser-Tyr-D-Arg-Trp-Leu-Pro-NHEt |
InChI | InChI=1S/C64H83N17O12/c1-4-68-62(92)53-16-10-24-81(53)63(93)51(25-35(2)3)79-58(88)48(27-37-30-70-43-13-7-5-11-41(37)43)76-55(85)45(15-9-23-69-64(65)66)74-57(87)47(26-36-17-19-40(83)20-18-36)75-61(91)52(33-82)80-59(89)49(28-38-31-71-44-14-8-6-12-42(38)44)77-60(90)50(29-39-32-67-34-72-39)78-56(86)46-21-22-54(84)73-46/h5-8,11-14,17-20,30-32,34-35,45-53,70-71,82-83H,4,9-10,15-16,21-29,33H2,1-3H3,(H,67,72)(H,68,92)(H,73,84)(H,74,87)(H,75,91)(H,76,85)(H,77,90)(H,78,86)(H,79,88)(H,80,89)(H4,65,66,69)/t45-,46+,47+,48+,49+,50+,51+,52+,53+/m1/s1 |
InChI Key | PYXUQVSYYFRRBD-OIAWHVPDSA-N |
Canonical SMILES | CCNC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 |
Isomeric SMILES | CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8 |
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.